| 产品描述: | Cagrilintide 是一种在研的新型长效酰化胰淀素类似物,作为非选择性的胰淀素受体 (AMYR) 和 降钙素 G 蛋白偶联受体 (CTR) 激动剂。Cagrilintide 可显着减轻体重并减少食物摄入。Cagrilintide 具有肥胖研究潜力。
{Eicosanedioic acid-γ-Glu}-Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 (Disulfide bridge:Cys3-Cys8)
{Eicosanedioic acid-γ-Glu}-KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP-NH2 (Disulfide bridge:Cys3-Cys8) |
| 体内研究: |
Cagrilintide (compound 23) (0.1, 1, 3, 10, 30 nmol/kg; s.c.) reduces food intake in the rat. Cagrilintide (10 nmol/kg; i.v. or s.c.) shows good pharmacokinetic parameters. |
| 参考文献: |
1. Fletcher MM, et al. AM833 Is a Novel Agonist of Calcitonin Family G Protein-Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists. J Pharmacol Exp Ther. 2021 Jun;377(3):417-440. 2. Kruse T, et al. Development of Cagrilintide, a Long-Acting Amylin Analogue. J Med Chem. 2021 Aug 12;64(15):11183-11194. 3. Dehestani B, et al. Amylin as a Future Obesity Treatment. J Obes Metab Syndr. 2021 Dec 30;30(4):320-325. |
| 保存条件: |
-20°C,干燥,避光,充氮 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0.227 ml |
1.134 ml |
2.268 ml |
| 5 mM |
0.045 ml |
0.227 ml |
0.454 ml |
| 10 mM |
0.023 ml |
0.113 ml |
0.227 ml |
| 50 mM |
0.005 ml |
0.023 ml |
0.045 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |